Literature DB >> 33411622

Comparisons of Real-World Time-to-Event End Points in Oncology Research.

Brigham Walker1, Marley Boyd1, Kat Aguilar1, Kalatu Davies1, Janet Espirito1, Jennifer Frytak1, Nicholas Robert1.   

Abstract

Year:  2021        PMID： 33411622     DOI： 10.1200/CCI.20.00125

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN： 2473-4276


× No keyword cloud information.
  3 in total

1.  Validation of Real-World Data-based Endpoint Measures of Cancer Treatment Outcomes.

Authors:  Qian Li; Hansi Zhang; Zhaoyi Chen; Yi Guo; Thomas J George; Yong Chen; Fei Wang; Jiang Bian
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

2.  Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study.

Authors:  David Waterhouse; Laura Iadeluca; Sneha Sura; Keith Wilner; Birol Emir; Stan Krulewicz; Janet Espirito; Lauren Bartolome
Journal:  Target Oncol       Date:  2021-12-29       Impact factor: 4.493

3.  Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors.

Authors:  George Chalkidis; Jordan McPherson; Anna Beck; Michael Newman; Shuntaro Yui; Catherine Staes
Journal:  JCO Clin Cancer Inform       Date:  2022-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.